Evidence map›Paper›PMID 42509746›Full record

ArticleBiomolecules2026

Hippocampal Mitochondrial Dysfunction and Synaptic Disruption Link Organophosphate Exposure to Pre-Diabetes: An LC-MS/MS-Based Proteomics Approach.

Vishal Sandilya, Rowan E Arida, Sherifdeen Onigbinde, Sarah Sahioun, Favour Chukwubueze, Hadi Al Sheikh, Heba-Tallah Abd Elrahim Abd Elkader, Salwa A Abuiessa, Mahmoud Agami, Mai M Helmy and 2 more

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vishal SandilyaDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0009-0006-5834-7404
Rowan E AridaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.ORCID 0009-0006-4740-1380
Sherifdeen OnigbindeDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0001-6791-7989
Sarah SahiounDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.
Favour ChukwubuezeDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0002-2779-8564
Hadi Al SheikhDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.
Heba-Tallah Abd Elrahim Abd ElkaderZoology, Biological, and Geological Sciences Department, Faculty of Education, Alexandria University, Alexandria 21526, Egypt.ORCID 0000-0003-2078-1193
Salwa A AbuiessaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Mahmoud AgamiFaculty of Pharmacy and Research & Innovation Hub, Alamein International University, Alamein 51718, Egypt.ORCID 0000-0003-0854-2819
Mai M HelmyDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Ahmed El-YazbiDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Yehia MechrefDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0002-6661-6073

Funding

The CH Foundation No NumberWelch Foundation D-0005
6 · The paper itself

Abstract

Organophosphate pesticides (OPPs) are widely used in agriculture and are associated with metabolic dysregulation and cognitive impairment. Emerging evidence links OPP exposure to insulin resistance and diabetes mellitus, a condition known to negatively impact brain function. Prior investigations in our laboratory identified significant dysregulation of arachidonic acid (AA) metabolites associated with the endocannabinoid system in both diabetic patients and those with chronic OPP exposure, with a marked reduction in serum AA levels in the OPP-exposed cohort. This study investigates the impact of OPP exposure and pre-diabetes on the hippocampal proteome and whether AA supplementation can mitigate the resulting neuronal proteomic alterations. Using a controlled rat model, high-resolution LC-MS/MS-based proteomics identified differentially expressed proteins across experimental groups. Both OPP exposure and pre-diabetes were associated with increased cognitive impairment and were associated with overlapping disruptions in pathways related to insulin resistance, mitochondrial function, synaptic plasticity, and neuronal development. AA supplementation mitigated cognitive decline and stabilized synaptic and metabolic proteins; however, residual pathway dysregulation highlights the complexity of these stressors. Our results reveal novel molecular intersections between environmental and metabolic drivers of cognitive impairment, establishing a rationale for further research into inexpensive, protective dietary interventions.

Indexed as

HippocampusMitochondriaOrganophosphatesPrediabetic StateProteomicsSynapsesAnimalsArachidonic AcidChromatography, LiquidCognitive DysfunctionLiquid Chromatography-Mass SpectrometryMaleProteomeRatsRats, Sprague-DawleyTandem Mass SpectrometryArachidonic AcidOrganophosphatesProteomearachidonic acidchlorpyrifoscognitive impairmenthippocampusLC-MS/MSmitochondrial dysfunctionorganophosphate exposurepre-diabetesproteomics

Identifiers

PMID42509746
PMCPMC13406760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.